Clinical Trial Update: The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass [Phase 2]

View source ↗

Summary

Phase 2 trial investigating estrogen replacement therapy in postmenopausal women with hypercalciuria and low bone mass, terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalciuria
• Osteopenia
• Osteoporosis

Drugs mentioned

• Estrogen Replacement Therapy (estrogen replacement therapy)

Snippet

Sponsor: University of Chicago | Conditions: Hypercalciuria, Hypercalciuria, Familial Idiopathic | Phase 2 | Status: TERMINATED | Results posted: 2018-03-07